Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

President, CEO, and CFO

Chief Scientific Officer

President and CEO

Chief Financial Officer

Head of Strategic Partnerships

SVP, Business Development

Kintara Therapeutics, Inc., a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients. It is developing two late-stage, Phase III-ready therapeutics, including VAL-083, a DNA-targeting agent for the treatment of drug-resistant solid tumors, such as glioblastoma multiforme, as well as other solid tumors, including ovarian cancer, non-small cell lung cancer, and diffuse intrinsic pontine glioma; and REM-001, a late stage photodynamic therapy for the treatment of cutaneous metastatic breast cancer, basal cell carcinoma nevus syndrome, and access graft failure in hemodialysis patients. Kintara Therapeutics, Inc. has a strategic collaboration with Guangxi Wuzhou Pharmaceutical (Group) Co. Ltd. to manufacture and sell VAL-083 in China. The company was formerly known as DelMar Pharmaceuticals, Inc. and changed its name to Kintara Therapeutics, Inc. in August 2020. Kintara Therapeutics, Inc. was incorporated in 2009 and is headquartered in San Diego, California.

Kintara Therapeutics, Inc., a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to ...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2023-06-01	Premium	acquired	Premium	Premium	Premium	President, CEO, and CFO
2023-01-05	Premium	acquired	Premium	Premium	Premium	Chief Scientific Officer
2022-08-01	Premium	acquired	Premium	Premium	Premium	President and CEO
2022-08-01	Premium	acquired	Premium	Premium	Premium	Chief Scientific Officer
2022-08-01	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2022-02-15	Premium	bought	Premium	Premium	Premium	President and CEO
2021-12-08	Premium	bought	Premium	Premium	Premium	Chief Financial Officer
2021-12-07	Premium	bought	Premium	Premium	Premium	Head of Strategic Partnerships
2021-12-06	Premium	bought	Premium	Premium	Premium	Head of Strategic Partnerships
2021-11-22	Premium	bought	Premium	Premium	Premium	-
2021-04-29	Premium	acquired	Premium	Premium	Premium	Chief Scientific Officer
2021-04-29	Premium	acquired	Premium	Premium	Premium	-
2021-04-29	Premium	acquired	Premium	Premium	Premium	-
2021-04-29	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2021-04-29	Premium	acquired	Premium	Premium	Premium	Chief Scientific Officer
2021-04-29	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2021-03-31	Premium	acquired	Premium	Premium	Premium	Chief Scientific Officer
2021-03-31	Premium	acquired	Premium	Premium	Premium	-
2021-03-31	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2020-12-31	Premium	acquired	Premium	Premium	Premium	Chief Scientific Officer
2020-12-31	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2020-12-31	Premium	acquired	Premium	Premium	Premium	-
2020-09-30	Premium	acquired	Premium	Premium	Premium	-
2020-09-30	Premium	acquired	Premium	Premium	Premium	Chief Scientific Officer
2020-09-30	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer

KTRA - Kintara Therapeutics, Inc. Stock Price, Fair Value and News

Latest Insider Trading transactions for KTRA